RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $155,632 | -17.6% | 23,870 | +4.8% | 0.00% | 0.0% |
| Q1 2024 | $188,983 | -22.7% | 22,769 | +2.6% | 0.00% | -50.0% |
| Q4 2023 | $244,345 | +29.1% | 22,193 | -1.4% | 0.00% | 0.0% |
| Q3 2023 | $189,284 | -32.0% | 22,507 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $278,342 | -25.8% | 22,161 | -2.7% | 0.00% | -33.3% |
| Q1 2023 | $375,005 | +13.8% | 22,769 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $329,427 | -16.8% | 22,050 | +24.5% | 0.00% | -25.0% |
| Q3 2022 | $396,000 | +34.2% | 17,717 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $295,000 | -15.7% | 17,606 | +50.7% | 0.00% | 0.0% |
| Q1 2022 | $350,000 | 0.0% | 11,682 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $350,000 | +25.9% | 11,401 | +29.5% | 0.00% | +50.0% |
| Q3 2021 | $278,000 | -11.7% | 8,807 | +2.4% | 0.00% | -33.3% |
| Q2 2021 | $315,000 | +15.8% | 8,601 | +9.5% | 0.00% | +50.0% |
| Q1 2021 | $272,000 | -16.3% | 7,858 | +0.4% | 0.00% | -33.3% |
| Q4 2020 | $325,000 | – | 7,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |